To summarise, we have shown that sFRP1 represses AR transcriptional activity and, as a result, inhibits proliferation of androgen-dependent prostate cancer cells and that the CRD is mainly responsible for both of these effects. Here, SFRP1 is linked to prostate carcinoma.